IGF-1 is a marker associated with growth hormone activity. You may see it discussed in a sermorelin consultation, but a result is not a diagnosis on its own. The reason for testing and the person’s clinical history matter as much as the number.
Routine wellness testing, monitoring a prescribed treatment, and confirming adult growth hormone deficiency are different tasks. A clinician should be able to explain which task a test serves and how the result would change the plan.
Ask what a test can answer and what action its result would change. A single IGF-1 value does not establish a need for anti-aging treatment.
Why a single growth hormone measurement is difficult to interpret
Growth hormone is released in pulses, so a single measurement may capture a different part of that pattern. IGF-1 is often discussed as a related marker, but it still needs clinical interpretation rather than a simple higher-is-better assumption.
Age, health conditions, and the reason for testing affect how results are understood. Ask which reference range applies and whether the result is consistent with the overall clinical picture. Do not compare yourself with a social-media target or a result from someone using a different laboratory.
How a deficiency evaluation differs
The Endocrine Society guideline explains that confirmation of adult growth hormone deficiency usually requires stimulation testing, except in defined circumstances such as certain established structural or genetic conditions.
That is different from seeing an age-related change and calling it a deficiency. If a clinician suspects pituitary disease, ask about the appropriate endocrine workup and whether a specialist should be involved. The treatment discussion should follow the diagnosis and the evidence for that condition.
What monitoring should accomplish
If treatment is prescribed, ask which symptoms, laboratory measures, or functional outcomes will be followed. A marker can inform a clinician about biological response without answering whether the patient’s original concern has improved.
Agree on how the clinician will balance the results with side effects and daily functioning. Do not raise, lower, or combine medications to chase a number without a clinician’s direction. A review can reasonably conclude that a treatment should be continued, changed, paused, or stopped.
Include testing in the cost comparison
Ask which tests are necessary, where they can be completed, and who reviews them. A large advertised panel may not be the same as the specific testing relevant to the clinical question. Additional tests may have separate charges.
Hone Health publishes membership and testing information, while other services structure those costs differently. Use an itemized estimate and ask how results will affect care. Buying a test is useful only when its purpose and interpretation are clear.
Other hormone and metabolic questions
Sermorelin is not testosterone replacement. The testosterone and TRT article explains why sexual symptoms, testosterone measurements, and fertility goals need their own evaluation. If you also use a weight-management medicine, read sermorelin and GLP-1 treatments.
Tell the clinician about diabetes, thyroid disease, blood-pressure concerns, and the medicines used for them. Mayo Clinic notes that an underactive thyroid can interfere with sermorelin’s effects. A clinician should decide which testing is relevant; an online review cannot declare that the treatment improves diabetes or blood pressure, or that it is safe with every existing condition.
A thyroid history changes the assessment too. Read sermorelin and thyroid conditions before interpreting fatigue or a single laboratory value.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- Endotext: Growth Hormone and AgingExpert clinical evidence review · Separates hormone and body-composition findings from functional outcomes and long-term unknowns.
- Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
- Hone Health: Sermorelin InjectionsProvider primary source · Medication and membership figures are displayed separately.
- Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- Endocrine Society: Testosterone therapy guidelineClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- NIDDK: Prescription medications for weight managementClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.